LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 50.05 | 770.25 | 1429 | 6629 | 0.2156 | 0.2202 | MN20160304_L02 | F07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 50.05 | 770.25 | 1668 | 6629 | 0.2516 | 0.2825 | MN20160304_L02 | J22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 52.27 | 770.25 | 1466 | 7058 | 0.2077 | 0.2231 | MN20160304_L02 | F07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 52.27 | 770.25 | 1671 | 7058 | 0.2367 | 0.2742 | MN20160304_L02 | J22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 54.49 | 770.25 | 1462 | 7555 | 0.1935 | 0.2148 | MN20160304_L02 | F07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 54.49 | 770.25 | 1752 | 7555 | 0.2319 | 0.2834 | MN20160304_L02 | J22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 56.71 | 770.25 | 1474 | 8001 | 0.1842 | 0.2119 | MN20160304_L02 | F07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 56.71 | 770.25 | 1717 | 8001 | 0.2146 | 0.2679 | MN20160304_L02 | J22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 58.94 | 770.25 | 1471 | 8444 | 0.1742 | 0.2060 | MN20160304_L02 | F07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 58.94 | 770.25 | 1734 | 8444 | 0.2053 | 0.2648 | MN20160304_L02 | J22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 61.16 | 770.25 | 1464 | 8892 | 0.1646 | 0.1996 | MN20160304_L02 | F07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 61.16 | 770.25 | 1680 | 8892 | 0.1889 | 0.2473 | MN20160304_L02 | J22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 63.39 | 770.25 | 1487 | 9326 | 0.1594 | 0.2006 | MN20160304_L02 | F07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 63.39 | 770.25 | 1691 | 9326 | 0.1813 | 0.2443 | MN20160304_L02 | J22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 65.61 | 770.25 | 1483 | 9736 | 0.1523 | 0.1960 | MN20160304_L02 | F07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 65.61 | 770.25 | 1688 | 9736 | 0.1734 | 0.2391 | MN20160304_L02 | J22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 67.83 | 770.25 | 1503 | 10078 | 0.1491 | 0.1975 | MN20160304_L02 | F07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 67.83 | 770.25 | 1665 | 10078 | 0.1652 | 0.2310 | MN20160304_L02 | J22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 70.05 | 770.25 | 1515 | 10413 | 0.1455 | 0.1973 | MN20160304_L02 | F07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 70.05 | 770.25 | 1698 | 10413 | 0.1631 | 0.2342 | MN20160304_L02 | J22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 72.27 | 770.25 | 1513 | 10730 | 0.1410 | 0.1944 | MN20160304_L02 | F07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 72.27 | 770.25 | 1719 | 10730 | 0.1602 | 0.2352 | MN20160304_L02 | J22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 74.50 | 770.25 | 1509 | 10991 | 0.1373 | 0.1917 | MN20160304_L02 | F07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 74.50 | 770.25 | 1715 | 10991 | 0.1560 | 0.2321 | MN20160304_L02 | J22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 76.75 | 770.25 | 1526 | 11262 | 0.1355 | 0.1932 | MN20160304_L02 | F07 |